Protean eGov Technologies files FY26 annual report with exchanges
- Protean eGov Technologies filed its FY26 Integrated Annual Report with BSE and NSE
- Filing complies with SEBI Listing Regulations 30 and 34
- Report is available electronically for registered members
- Document accessible via company website and NSDL portal

*this image is generated using AI for illustrative purposes only.
Protean eGov Technologies Limited has filed its Integrated Annual Report for the financial year 2025-26 with the Bombay Stock Exchange and the National Stock Exchange of India.
The filing was made pursuant to Regulation 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company disclosed that the report is being sent via electronic mode only to members who have registered their email addresses with the company or their depository participants.
Report Accessibility
The Integrated Annual Report is accessible to investors through multiple digital channels. It is available on the company’s official website at proteantech.in/financial-reports. Additionally, shareholders can access the document via the National Securities Depository Limited (NSDL) website at evoting.nsdl.com.
Corporate Governance
The disclosure was signed by Maulesh J Kantharia, the Company Secretary and Compliance Officer of Protean eGov Technologies Limited. The filing reference number is Protean/Secretarial/2026-27/38, dated August 28, 2026.
Historical Stock Returns for Protean e-Gov Technologies
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.31% | -1.53% | -13.74% | -8.53% | -38.90% | 0.0% |
What key financial metrics or strategic initiatives highlighted in the FY 2025-26 report are expected to drive Protean's revenue growth in the upcoming fiscal year?
How might the shift to exclusively electronic distribution of annual reports impact shareholder engagement and accessibility for non-digital investors?
Are there any new regulatory compliance challenges or SEBI guideline updates referenced in the report that could affect Protean's operational costs?


































